The Valley Desk

NCT00633789 · Interventional trial

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Overall registry status Completed

Phase 2

Conditions Advanced Non-small Cell Lung Cancer, Gastric/Esophageal Adenocarcinoma, Pancreatic Cancer Including Ampulla of Vater, Soft Tissue Sarcoma, Transitional Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov